Clinical Trial Update: Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating reversal of neuromuscular blockade with sugammadex versus usual care in hip fracture surgery and hip/knee arthroplasty; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthroplasty Replacement Hip
• Arthroplasty Replacement Knee
• Hip Fracture
• Total Hip Arthroplasty
• Total Knee Arthroplasty

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neuromuscular Blockade, Arthroplasty, Replacement, Hip | Phase 3 | Status: COMPLETED | Results posted: 2013-10-30